메뉴 건너뛰기




Volumn 57, Issue 5, 2012, Pages 372-380

Dual properties of anticancer agents: An exploratory study on the in vitro anti-candida properties of thirty drugs

Author keywords

Anticancer agent; Antifungal activity; Antifungal agent; Candida albicans; Drug resistance; Minimum inhibitory concentration

Indexed keywords

ALKYLATING AGENT; ANTIESTROGEN; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; AROMATASE INHIBITOR; BLEOCIP; BLEOMYCIN; BUSULFAN; CISPLATIN; CYTOPLATI; DACARBAZINE; DACARIN; DNA TOPOISOMERASE INHIBITOR; DOCET; DOCETAXEL; EPIPODOPHYLLOTOXIN; ESIDE; ETOPOSIDE; FASTIVORIN; FLUCONAZOLE; FOLINIC ACID; FORMESTANE; GEMCITABINE; GEMSPERA; GONADORELIN AGONIST; IRINOTECAN; LEUPROFACT; LEUPRORELIN; PACLISTAR; PACLITAXEL; PLATINUM DERIVATIVE; TAMOXIFEN; TAMOXIFEN CITRATE; UNCLASSIFIED DRUG; VINBLASTINE; VINBLASTINE SULFATE; VINCRISTINE; VINCRISTINE SULFATE;

EID: 80053929848     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000330454     Document Type: Article
Times cited : (24)

References (40)
  • 1
    • 0034117209 scopus 로고    scopus 로고
    • Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries - Are there differences from developed countries?
    • Arendorf T, Holmes H: Oral manifestations associated with human immunodeficiency virus (HIV) infection in developing countries-are there differences from developed countries? Oral Dis 2000; 6:133-135. (Pubitemid 30344983)
    • (2000) Oral Diseases , vol.6 , Issue.3 , pp. 133-135
    • Arendorf, T.1    Holmes, H.2
  • 3
    • 63849233258 scopus 로고    scopus 로고
    • The changing face of epidemiology of invasive fungal disease in Europe
    • Lass-Florl C: The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 19 7-2 0 5.
    • (2009) Mycoses , vol.52 , pp. 197-205
    • Lass-Florl, C.1
  • 4
    • 67650723105 scopus 로고    scopus 로고
    • Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: A review of the literature (2005-2009)
    • Espinel-Ingroff A: Novel antifungal agents, targets or therapeutic strategies for the treatment of invasive fungal diseases: a review of the literature (2005-2009). Rev Iberoam Mi-col 2009; 26: 15-2 2.
    • (2009) Rev Iberoam Mi-col , vol.26 , pp. 15-22
    • Espinel-Ingroff, A.1
  • 5
    • 0002277869 scopus 로고
    • Invasive fungal infections: Problem and challenges for developing new anti-fungal compounds; In
    • Ssutcliffe J, Gergopa-padakou NH (eds) N.Y., Chapman and Hall
    • Walsh TJ: Invasive fungal infections: problem and challenges for developing new anti-fungal compounds; in Ssutcliffe J, Gergopa-padakou NH (eds): Emerging Targets in Antibacterial and Antifungal Chemotherapy. N.Y., Chapman and Hall, 1992, pp 349-373.
    • (1992) Emerging Targets in Antibacterial and Antifungal Chemotherapy. , pp. 349-373
    • Walsh, T.J.1
  • 6
    • 33846466508 scopus 로고    scopus 로고
    • Epidemiology of invasive candidiasis: A persistent public health problem
    • DOI 10.1128/CMR.00029-06
    • Pfaller MA, Diekema DJ: Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133-163. (Pubitemid 46167771)
    • (2007) Clinical Microbiology Reviews , vol.20 , Issue.1 , pp. 133-163
    • Pfaller, M.A.1    Diekema, D.J.2
  • 7
    • 4644248400 scopus 로고    scopus 로고
    • Development and characterization of an in vivo central venous catheter candida albicans biofilm model
    • A nde s D, Ne t t J, Oschel P, A lb er t R, Ma rchi l-lo K, Pitula A: Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Im-mun 2004; 72:6023-6031.
    • (2004) Infect Im-mun , vol.72 , pp. 6023-6031
    • Andes, D.1    Nett, J.2    Oschel, P.3    Albert, R.4    Marchil-Lo, K.5    Pitula, A.6
  • 8
    • 71249123989 scopus 로고    scopus 로고
    • Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs
    • Swoboda S, Lichtenstern C, Ober MC, Taylor LA, Störzinger D, Michel A, et al: Implementation of practice guidelines for antifungal therapy in a surgical intensive care unit and its impact on use and costs. Chemotherapy 2009; 55:418-424.
    • (2009) Chemotherapy , vol.55 , pp. 418-424
    • Swoboda, S.1    Lichtenstern, C.2    Ober, M.C.3    Taylor, L.A.4    Störzinger, D.5    Michel, A.6
  • 9
    • 70350026151 scopus 로고    scopus 로고
    • Antifun-gal drug resistance mechanisms in fungal pathogens from the perspective of transcrip-tional gene regulation
    • Sanglard D, Coste A, Ferrari S: Antifun-gal drug resistance mechanisms in fungal pathogens from the perspective of transcrip-tional gene regulation. FEMS Yeast Res 2009; 9: 1029-105 0.
    • (2009) FEMS Yeast Res , vol.9 , pp. 1029-1050
    • Sanglard, D.1    Coste, A.2    Ferrari, S.3
  • 10
    • 33748933537 scopus 로고    scopus 로고
    • Current status of antifungal therapy for systemic mycoses
    • Nosanchuk JD: Current status of antifungal therapy for systemic mycoses. Recent Pat Antiinfect Drug Discov 20 06; 1: 75-84.
    • (2006) Recent Pat Antiinfect Drug Discov , vol.1 , pp. 75-84
    • Nosanchuk, J.D.1
  • 11
    • 0142134314 scopus 로고    scopus 로고
    • Antifungal agents: Their diversity and increasing sophistication
    • DOI 10.1017/S0269915X03002064
    • Odds FC: Antifungal agents: their diversity and increasing sophistication. Mycologist 2003; 17: 51-5 5. (Pubitemid 37292991)
    • (2003) Mycologist , vol.17 , Issue.2 , pp. 51-55
    • Odds, F.C.1
  • 16
    • 50449104506 scopus 로고    scopus 로고
    • Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi
    • Borelli C, Schaller M, Niewerth M, Nocker K, Baasner B, Berg D, et al: Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi. Chemotherapy 2008; 54:245-259.
    • (2008) Chemotherapy , vol.54 , pp. 245-259
    • Borelli, C.1    Schaller, M.2    Niewerth, M.3    Nocker, K.4    Baasner, B.5    Berg, D.6
  • 17
    • 66749184717 scopus 로고    scopus 로고
    • Microtubules and actin cytoskeletons of potentially pathogenic basidiomycetous yeast as targets for antifun-gals
    • Kopecká M, Gabriel M: Microtubules and actin cytoskeletons of potentially pathogenic basidiomycetous yeast as targets for antifun-gals. Chemotherapy 2009; 55:278-286.
    • (2009) Chemotherapy , vol.55 , pp. 278-286
    • Kopecká, M.1    Gabriel, M.2
  • 18
    • 0032823635 scopus 로고    scopus 로고
    • Antifungal activities of antineoplastic agents: Saccharomyces cerevisiae as a model system to study drug action
    • Cardenas ME, Cruz MC, Del Poeta M, Chung N, Perfect JR, Heitman J: Antifungal activities of antineoplastic agents: Saccharo-myces cerevisiae as a model system to study drug action. Clin Microbiol Rev 1999; 12: 583-611. (Pubitemid 29484748)
    • (1999) Clinical Microbiology Reviews , vol.12 , Issue.4 , pp. 583-611
    • Cardenas, M.E.1    Cruz, M.C.2    Del Poeta, M.3    Chung, N.4    Perfect, J.R.5    Heitman, J.6
  • 20
    • 2342509759 scopus 로고    scopus 로고
    • Dual purpose: Some cancer therapies used to treat autoimmune diseases
    • Ben-Ari ET: Dual purpose: some cancer therapies used to treat autoimmune diseases. J Natl Ca ncer Inst 2004; 96: 577-579. (Pubitemid 38584977)
    • (2004) Journal of the National Cancer Institute , vol.96 , Issue.8 , pp. 577-579
    • Ben-Ari, E.T.1
  • 21
    • 0025164671 scopus 로고
    • Combinations of antifungal and antineoplastic drugs with interactive effects on inhibition of yeast growth
    • Ghannoum MA, Abu-Elteen KH, Motaway MS, Abu-Hatab MA, Ibrahim AS, Criddle RS: Combinations of antifungal and anti-neoplastic drugs with interactive effects on inhibition of yeast growth. Chemotherapy 1990; 36:308-320. (Pubitemid 20251913)
    • (1990) Chemotherapy , vol.36 , Issue.4 , pp. 308-320
    • Ghannoum, M.A.1    Abu-Elteen, K.H.2    Motawy, M3    S.4    Abu-Hatab, M.A.5    Ibrahim, A.S.6    Criddle, R.S.7
  • 23
    • 26844437212 scopus 로고    scopus 로고
    • Morphological and growth altering effects of cisplatin in c. Albicans using fluorescence microscopy
    • Kesavan C, Raghunathan M, Ganesan N: Morphological and growth altering effects of cisplatin in C. albicans using fluorescence microscopy. Ann Clin Microbiol Antimi-crob 2005; 4:1-4.
    • (2005) Ann Clin Microbiol Antimi-crob , vol.4 , pp. 1-4
    • Kesavan, C.1    Raghunathan, M.2    Ganesan, N.3
  • 24
    • 30744433912 scopus 로고    scopus 로고
    • 5-Fluorouracil altered morphology and inhibited growth of Candida albicans [3]
    • DOI 10.1128/JCM.43.12.6215-6216.2005
    • Kesavan C, Joyee AG: 5-Fluorouracil altered morphology and inhibited growth of C. albi-cans. J Clin Microbiol 2005; 43: 6215-6216. (Pubitemid 43100698)
    • (2005) Journal of Clinical Microbiology , vol.43 , Issue.12 , pp. 6215-6216
    • Kesavan, C.1    Joyce, A.G.2
  • 26
    • 18544390708 scopus 로고    scopus 로고
    • Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases
    • DOI 10.1128/JCM.43.5.2155-2162.2005
    • Richter SS, Galask R P, Diekema DJ, Messer SA, Pfaller MA, Hollis RJ: Antifungal susceptibilities of Candida species causing vul-vovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005; 43:2155-2162. (Pubitemid 40656220)
    • (2005) Journal of Clinical Microbiology , vol.43 , Issue.5 , pp. 2155-2162
    • Richter, S.S.1    Galask, R.P.2    Messer, S.A.3    Hollis, R.J.4    Diekema, D.J.5    Pfaller, M.A.6
  • 27
    • 0346732026 scopus 로고    scopus 로고
    • Effects of Aspirin and Other Nonsteroidal Anti-Inflammatory Drugs on Biofilms and Planktonic Cells of Candida albicans
    • DOI 10.1128/AAC.48.1.41-47.2004
    • Alem MA, Douglas LJ: Effect of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrob Agents Chemother 2004; 48:41-47. (Pubitemid 38040174)
    • (2004) Antimicrobial Agents and Chemotherapy , vol.48 , Issue.1 , pp. 41-47
    • Alem, M.A.S.1    Douglas, L.J.2
  • 28
  • 29
    • 65649117884 scopus 로고    scopus 로고
    • Amiodarone and itraconazole: A rational therapeutic approach for the treatment of chronic chagas' disease
    • Paniz-Mondolfi AE, Pérez-Álvarez AM, Lanza G, Márquez E, Concepción JL: Amiodarone and itraconazole: a rational therapeutic approach for the treatment of chronic Chagas' disease. Chemotherapy 2009; 55:228-233.
    • (2009) Chemotherapy , vol.55 , pp. 228-233
    • Paniz-Mondolfi, A.E.1    Pérez-Álvarez, A.M.2    Lanza, G.3    Márquez, E.4    Concepción, J.L.5
  • 30
    • 0030667434 scopus 로고    scopus 로고
    • Integrating genetic approaches into the discovery of anticancer drugs
    • DOI 10.1126/science.278.5340.1064
    • Hartwell LH, Szankasi P, Roberts CJ, Murray AW, Friend SH: Integrating genetic approaches into the discovery of anticancer drugs. Science 1997; 251:1064-1068. (Pubitemid 27517876)
    • (1997) Science , vol.278 , Issue.5340 , pp. 1064-1068
    • Hartwell, L.H.1    Szankasi, P.2    Roberts, C.J.3    Murray, A.W.4    Friend, S.H.5
  • 34
    • 0036947856 scopus 로고    scopus 로고
    • Prospective evaluation of Candida species colonization in hospitalized cancer patient: Impact on short-term survival in recipients of marrow transplatation and patients with hematological malignancies
    • DOI 10.1038/sj.bmt.1703732
    • Safdar A, Armstrong D: Prospective evaluation of Candida species colonization in hospitalized cancer patients: impact on short-term survival in recipients of marrow transplantation and patients with hematologi-cal malignancies. Bone Marrow Transplant 2002; 30:931-935. (Pubitemid 36097483)
    • (2002) Bone Marrow Transplantation , vol.30 , Issue.12 , pp. 931-935
    • Safdar, A.1    Armstrong, D.2
  • 36
    • 0036025365 scopus 로고    scopus 로고
    • Resistance amongst yeast isolated from the oral cavities of patients with advanced cancer
    • DOI 10.1191/0269216302pm583oa
    • Davies A, Brailsford S, Broadley K, Beighton D: Resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer. Palliat Med 2000; 16:527-531. (Pubitemid 35386012)
    • (2002) Palliative Medicine , vol.16 , Issue.6 , pp. 527-531
    • Davis, A.1    Brailsford, S.2    Broadley, K.3    Beighton, D.4
  • 37
    • 0034093263 scopus 로고    scopus 로고
    • New drugs and novel targets for treatment of invasive fungal infections in patients with cancer
    • Chiou CC, Groll AH, Walsh TJ: New drugs and novel targets for treatment of invasive fungal infections in patients with cancer. Oncologist 2000; 5:120-135. (Pubitemid 30238232)
    • (2000) Oncologist , vol.5 , Issue.2 , pp. 120-135
    • Chiou, C.C.1    Groll, A.H.2    Walsh, T.J.3
  • 39
    • 0033972985 scopus 로고    scopus 로고
    • A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer
    • DOI 10.1016/S0002-9343(99)00457-X, PII S000293439900457X
    • Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC: A multicenter, randomized trial of fluconazole versus ampho-tericin B for empiric antifungal therapy of febrile neutropenic patients with cancer. Am J Med 2000; 108:282-289. (Pubitemid 30110456)
    • (2000) American Journal of Medicine , vol.108 , Issue.4 , pp. 282-289
    • Winston, D.J.1    Hathorn, J.W.2    Schuster, M.G.3    Schiller, G.J.4    Territo, M.C.5
  • 40
    • 33845748649 scopus 로고    scopus 로고
    • Fluconazole for empiric antifun-gal therapy in cancer patients with fever neu-tropenia
    • Yu DT, Seger DL, Peterson JF, Kumar RN, Bates DW: Fluconazole for empiric antifun-gal therapy in cancer patients with fever neu-tropenia. BMC Infect Dis 2006; 6:1-10.
    • (2006) BMC Infect Dis , vol.6 , pp. 1-10
    • Yu, D.T.1    Seger, D.L.2    Peterson, J.F.3    Kumar, R.N.4    Bates, D.W.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.